FDA accepts NDA for Aricept Patch for Alzheimer's disease (AD) - ONA
Links shared publicly online about this topic.
- 867total visits
FDA accepts NDA for Aricept Patch for Alzheimer's disease (AD) - ONA
View full resource at oncologynurseadvisor.com
Tags: Alzheimer's Disease, Alzheimer's Disease Medication, Disease and Condition, Drug, FDA, Aricept, Eisai, disease
Most Recently Shared on September 17, 2010 at 2:45 pm By:
FDA accepts NDA for Aricept Patch for Alzheimer's disease (AD) http://goo.gl/fb/8E9Zg
FDA Accepts Aricept, Patch (Donepezil Transdermal System) NDA For Review - QualityPoint Technologies
qualitypointtech.net — “Teikoku Pharma USA, Inc., an international specialty pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for a new weekly transdermal patch of Aricept,, a leading medication for the treatment of Alzheimer's disease. The company developed the weekly Aricept(r) patch based on a license agreement executed between Teikoku Pharma USA, Inc. and Eisai Co., Ltd. (Eisai) in February 2009. The acceptance of the NDA indic” View full resource at qualitypointtech.net
Most Recently Shared on September 18, 2010 at 8:13 pm By:
FDA Accepts Aricept® Patch (Donepezil Transdermal System) NDA For Review: Teikoku Pharma USA, Inc., an internat... http://bit.ly/cojyJC
FDA accepts to review Aricept NDA for Alzheimer's disease
news-medical.net — “Teikoku Pharma USA, Inc., an international specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for a new weekly transdermal patch of Aricept, a leading medication for the treatment of Alzheimer's disease.” View full resource at news-medical.net
Most Recently Shared on September 18, 2010 at 4:29 am By:
FDA accepts to review Aricept NDA for Alzheimer's disease: Teikoku Pharma USA, Inc., an international specialty ph... http://bit.ly/9cGJqS
FDA accepts NDA for Aricept Patch for Alzheimer's disease (AD) - MPR
empr.com — “Eisai announced that the FDA has accepted for filing the New Drug Application (NDA) submitted for Aricept Patch (donepezil transdermal system) for the treatment of mild, moderate and severe stages of Alzheimer's disease (AD).” View full resource at empr.com
Most Recently Shared on September 17, 2010 at 2:37 pm By:
MPR News: FDA accepts NDA for Aricept Patch for Alzheimer's disease (AD): Eisai announced that the FDA has accepte... http://bit.ly/9k1xUg
FDA accepts NDA for extended release Aricept, a treatment for Alzheimer's disease (AD) - MPR
empr.com — “Eisai and Pfizer announced that the FDA has accepted for review the New Drug Application (NDA) for once-daily 23 mg Aricept (donepezil HCl extended release tablets) for the treatment of moderate to severe Alzheimer's disease (AD).” View full resource at empr.com
Most Recently Shared on November 25, 2009 at 3:51 pm By:
MPR News: FDA accepts NDA for extended release Aricept, a treatment for Alzheimer's disease (AD): Eisai and Pfizer ... http://bit.ly/6GSvRg
Advertisement
